Pri-Med and Learn More Breathe BetterSM, a program of the National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health, are partnering to provide primary care clinicians with information on the updates to the national guidelines for the diagnosis, management, and treatment of asthma. 

Understanding the 2020 Focused Updates to the Asthma Management Guidelines is a two-part podcast series informing clinicians about the updated asthma guidance, highlighting important changes to the recommendations, and discussing how these changes can improve diagnosis, treatment, and management of patients with asthma. 

Learning Objectives

  • Discuss the background behind the 2020 Focused Updates to the Asthma Management Guidelines 
  • Outline the key topic areas covered in the 2020 Focused Updates 
  • Review the rigorous process used to update 2020 Focused Updates
  • Summarize the new features designed to help clinicians implement the 2020 Focused Updates practice
  • Review recommendations to the 2020 Focused Updates to the Asthma Management Guidelines that are most relevant to primary care providers
  • Discuss how clinicians can incorporate new information from the 2020 Focused Updates into practice 




Michelle M. Cloutier, MD

Chair of the NAEPPCC Expert Panel Working Group
Professor Emerita, UCONN School of Medicine
Hartford, CT

James P. Kiley, PhD

Director, Division of Lung Diseases, National Heart, Lung, and Blood Institute,
National Institutes of Health 
Bethesda, MD

Pamela Kushner, MD, FAAFP

Clinical Professor
Director, Kushner Wellness
UC Irvine Medical Center
Orange, CA 


Fine Print

The preferred browser is Google Chrome. If using a different browser, such as Safari, Firefox or Edge, make sure you are using the most up-to-date version. Your Internet settings should be set to accept cookies and JavaScript. If cookies and/or JavaScript are disabled, the site may not function properly. A high-speed Internet connection is not required; however, it is recommended for faster download times.

The opinions, ideas, and recommendations expressed in this educational activity are those of the faculty only and are not necessarily endorsed by, nor do they necessarily reflect, those of their affiliated institutions, Pri-Med Institute, Pri-Med Institute Advisory Boards and Consultants, DBC Pri-Med, LLC.

Clinical judgment must guide each clinician in weighing the possible risks, benefits, or contraindications of any diagnostics, interventions or treatments discussed. Clinicians should review manufacturers’ product information and consider these with the recommendations of other authorities when applying the assessment and/or clinical management strategies discussed in this activity to the care of their patients. Data, indications, and guidelines presented in this activity are current as of the activity release date and they are subject to change as new information is published.

Pri-Med Institute educational activities are developed and conducted in accordance with the ACCME's Essential Areas and Policies. It is the mission of Pri-Med Institute to develop and present educational activities that are timely, fair-balanced, scientifically rigorous, and that serve to improve patient outcomes. To that end, we welcome your comments about how to better serve your needs.

Pri-Med Institute Accredited Provider
Pri-Med programs are owned and operated by DBC Pri-Med, LLC, a division of Diversified Communications, Inc. Pri-Med Institute, the accredited division of Pri-Med, is accredited with commendation by the ACCME and approved as a provider of continuing education by the AANP. Pri-Med Institute is the accredited provider for this activity.

Disclosures and Conflict of Interest
Pri-Med Institute requires all individuals in a position to influence educational content for Pri-Med Institute-certified CME/CE activities to disclose relevant personal financial relationships with commercial interests prior to contributing to its educational activities. Pri-Med Institute assesses disclosed relationships and follows a defined process to resolve real or implied conflicts to ensure, to the best of its ability, that all educational content is free of commercial bias. Financial disclosures are listed in the activity syllabus and will also be printed on the slides and announced at the start of each presentation.

Discussion of Off-Label Uses and Investigational Products
During the course of their presentations, the faculty may mention uses of products that have not been approved in the United States for the indication(s) being discussed. All presenters are instructed to notify participants when they are discussing unapproved uses or investigational agents. In addition, specific slides will include notation of the off-label use or investigational agent being discussed. Views presented related to unapproved uses of products are solely those of the presenter(s) and are not endorsed by Pri-Med Institute or DBC Pri-Med, LLC.

Questions? If you have questions about this activity, please email support@pri-med.com or call (877) 477-4633.